Targeting STAU1 ameliorates disease phenotypes in TDP-43 ALS mice
Abstract Altered RNA metabolism and impaired proteostasis are central to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). STAU1 is a multifunctional RNA-binding protein that regulates mRNA decay and trafficking, interacts with ATXN2, and is overabundant in neurodegenerative disease models. STAU1 overabundance activates mTOR signaling, impairs autophagy and stress-granule turnover, and thereby participates in a feed-forward circuit that further elevates STAU1 abundance. Here, we tested whether genetic and antisense oligonucleotide (ASO)-mediated STAU1 lowering can interrupt this circuit in TDP-43-associated disease. Stau1 haploinsufficiency in Prp -TDP-43 Q331K mice improved motor performance and open-field measures, reduced TDP-43 and gliosis, normalized neuronal, apoptotic, and autophagy markers, restored TDP-43-dependent splicing, and attenuated transcriptomic abnormalities. Screening 2′- O -methoxyethyl (MOE) gapmer ASOs identified ASO-45, which lowered STAU1 in patient-derived fibroblasts and mouse CNS. Intracerebroventricular ASO-45 improved spinal-cord and motor-cortex phenotypes, restored splicing, and attenuated cortical transcriptomic abnormalities. In independent Thy1 -TDP-43 models, ASO-45 improved molecular markers and extended survival by 9.5–15.7%. These findings show that STAU1 lowering can disrupt a self-amplifying mTOR–autophagy–stress-granule axis and nominate STAU1-directed ASOs as a disease-modifying strategy for ALS/FTD.
Authors
- Collin J. Anderson (ORCID: https://orcid.org/0000-0002-6085-7773)
- Sharan Paul (ORCID: https://orcid.org/0000-0002-9845-3125)
- Mandi Gandelman (ORCID: https://orcid.org/0000-0003-2697-0390)
- Warunee Dansithong
- Pravin Hivare (ORCID: https://orcid.org/0000-0001-7746-1081)
- Malte Spielmann (ORCID: https://orcid.org/0000-0002-0583-4683)
- Stefan M. Pulst (ORCID: https://orcid.org/0000-0003-0883-7879)
- Jinze Li (ORCID: https://orcid.org/0000-0001-9108-6927)
- Karla Patricia Figueroa (ORCID: https://orcid.org/0000-0003-4857-9288)
Institutions
- The University of Sydney (AU)
- University of Utah (US)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-17
- DOI
- https://doi.org/10.21203/rs.3.rs-11750300/v1
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- preprint
Funders
- U.S. Department of Defense
- National Institute of Neurological Disorders and Stroke